Epidemiological studies of multiple sclerosis (MS) have shown the importance of genetic
susceptibility factors that are modified by as yet unknown environmental influences. The …

Multiple sclerosis, when described clinically in 1868, was considered a medical curiosity.
Today, with the recognition of the variety of clinical forms that this syndrome may take, it is …

Epidemiological studies of multiple sclerosis have been performed on almost an industrial
scale over the past 90 years. Morbidity statistics have been used to generate aetiological …

The multiple sclerosis (MS) case-control ratio by state originating from the US veteran series
from World War II (Kurtzke Neurology 1979; 29: 1228–1235) was geographically compared …

A genetic contribution to susceptibility is well established in multiple sclerosis (MS) and 57
associated genetic loci have been identified. We have undertaken a meta-analysis of …

Morbidity statistics for multiple sclerosis have been surveyed in many places, on many
occasions and for many reasons. Listing individuals in whom the diagnosis has already …

Who Is Affected by and at Risk of MS? About 900 000 people in the US have MS. Onset of
symptoms typically occurs at age 20 to 30 years. Women are nearly 3 times more likely to …

Pathogenesis of multiple sclerosis : Current Opinion in Neurology Pathogenesis of multiple
sclerosis : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new …

The epidemiology of multiple sclerosis (MS) has been thoroughly studied in developed
countries, particularly in areas traditionally known for their high prevalence. However, there …

Background and aim: Epidemiological studies of multiple sclerosis suggest a trend of
increasing disease prevalence in susceptible populations. The reasons for this are unclear …